Live site data
Công Ty Cổ Phần Dược Phẩm Bắc Ninh - BANIPHAR
Là doanh nghiệp hoạt động trong lĩnh vực sản xuất kinh doanh Dược phẩm, Dược liệu, Trang thiết bị vật tư y tế và Mỹ phẩm nhập khẩu BA LAN
Last refresh
Updated 6d ago
Analyst read
In review
#4.9M global rank53/100 trust
Detected stack
WordPressWooCommercejQuery
Quick read
How to read baniphar.com quickly
baniphar.com looks like an uncategorized property. Traffic signals point to roughly 2.9K monthly visits. Current AI trust scoring is 53/100.
What to do next
- The stack appears to include WordPress, WooCommerce.
- Open the Traffic tab if you need audience scale and geography before outreach.
- Open the Business tab if trust, monetization, or positioning is your first decision filter.
Provider Completeness
43/74 fields populated (58%)
2 health alerts13 providers
Providers with missing fields
dns: 3/4ads: 3/5publisher: 4/5authority: 0/5history: 0/7whois: 0/6radar: 2/4ai: 0/7
Provider health alerts
authority: AHREFS_DR_FETCH_FAILEDhistory: ARCHIVE_HISTORY_RATE_LIMITED
View field-level status
visual: 4/4
All expected fields present
meta: 3/3
All expected fields present
AI analysis not available
Business intelligence will appear here once the AI analysis completes.
Keep exploring
Keep exploring from this report
Browse the related category, topic, or technology path, open alternatives, or move into comparison when you have a second domain.
Related technology
Browse Wordpress websites
Pivot from one domain into a stack-based discovery path.
Technology pages help you compare implementation patterns across similar sites.
Related technology
Browse Woocommerce websites
Pivot from one domain into a stack-based discovery path.
Technology pages help you compare implementation patterns across similar sites.
Alternatives
Open baniphar.com alternatives
Review similar domains ranked by category, audience, technology overlap, and match reasons.
Use alternatives when this report is the start of a shortlist.
Comparison
Compare similar domains
Choose an alternative and move into a side-by-side comparison from the alternatives path.